This trial is testing whether two different tests can show why patients who have had a kidney transplant and have developed antibodies against their donor are at a greater risk for their transplanted organ being rejected.
1 Primary · 0 Secondary · Reporting Duration: Post bone marrow collection
80 Total Participants · 1 Treatment Group
Primary Treatment: bone marrow aspirations · No Placebo Group · N/A
Age 18 - 99 · All Participants · 3 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: